DRKS00016070招募中不适用
ERASE_Evaluation of early treatment response of soft tissue sarcomas under neoadjuvant hyperthermia and chemotherapy using functional MRI as well as FDG PET-CT - ERASE
Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 35 人开始时间: 2023年2月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Soft tissue sarcoma of the extremities in tumor stage AJCC III with indication for neoadjuvant combined chemotherapy/hyperthermia
- •- Tumor board decision for treatment chemotherapy/hyperthermia
- •- Indication for MRI and PET-CT examinations as part of clinical care for soft tissue sarcoma
- •- > 18 years male/female
- •- GFR value >30ml/min
- •- Signed declaration of consent
排除标准
- •- Contraindications to MRI examination, especially implants not suitable for MR, tattoos or piercings, pronounced claustrophobia
- •- Lack of consent and/or lack of ability to consent to the study
- •- Pregnancy
- •- Known allergy to MR contrast agent or PET-CT tracer
- •- GFR < 30 ml/min with renal insufficiency
研究者
相似试验
已完成
不适用
Evaluation of early treatment response and volumetric dose evaluation to target and organ at risk (small bowel/bladder/rectum) during radiation therapy of cervical cancer.CTRI/2022/03/040851AIIMS21
已完成
不适用
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging.C43.9Malignant melanoma of skin, unspecifiedDRKS00013925niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie62
进行中（未招募）
不适用
Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naive - DMARD early RA-patients. - LEADERPatients with a diagnosis of early active rhematoid arthritis in the previous 6 months, naive of previous treatment by DMARD and who need to be treated by DMARD.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-000886-40-ITsanofi-aventis Groupe200
进行中（未招募）
不适用
Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naïve-DMARD early RA-patients. - LEADERpatients with a diagnosis of early active rheumatoid arthritis in the previous 6 months, naïves of previous treatment by a DMARD and who need to be treated by a DMARDMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-000886-40-PTsanofi-aventis groupe200
进行中（未招募）
1 期
Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naïve-DMARD early RA-patients. - LEADERpatients with a diagnosis of early active rheumatoid arthritis in the previous 6 months, naïves of previous treatment by a DMARD and who need to be treated by a DMARDMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-000886-40-CZsanofi-aventis groupe200